Mary Szomjassy
Chief Clinical Officer, Canvas Therapeutics / Polite / Revida Labs
Mary holds an M.Ed from WWU and has been focused on the study of cannabinoid pharmacology and practical applications for over two decades. She enjoys active collaboration with researchers from various disciplines in cannabis, medicine and education. Mary is dedicated to studying trends in data and patient responses to help guide medical professionals and patients towards developing a greater understanding of the beneficial impacts of purposeful cannabinoid formulations and dosing protocols. She focuses on sharing her expertise at the Advanced Integrative Medical Science Institute in Seattle as well as lecturing through international medical conferences including Cambia Palliative Care Conference, UW; Swedish Oncology Symposium among others.